Literature DB >> 7730136

Detection of p53 gene mutations in aspiration biopsy specimens from suspected breast cancers by polymerase chain reaction-single strand conformation polymorphism analysis.

T Sato1, A Okazaki, M Okazaki, S Takahashi, K Hirata.   

Abstract

Genomic DNA was extracted from aspiration biopsy specimens taken from 15 suspected cases of breast cancer, including 7 known cases of breast cancer, and the p53 gene was studied for evidence of mutation by using a polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis. In 5 of the 15 cases (33%), p53 gene mutation was identified and these tumors were subsequently histologically diagnosed as malignant. Further, DNA flow cytometry of the 15 tumors demonstrated that 6 (40%) were aneuploid and malignant, whereas 9 (60%) were diploid and benign. It was also found that the tumor cells in 5 aspirated cases that showed p53 gene mutations were all aneuploid, the p53 protein expression was positive, and the tumors were proved to be histologically malignant. It was thus concluded that the detection of p53 gene mutation by PCR-SSCP analysis of aspirated biopsy specimens from suspected breast cancers is a helpful method for achieving a more accurate diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 7730136      PMCID: PMC5920757          DOI: 10.1111/j.1349-7006.1995.tb03031.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

1.  Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.

Authors:  A Foti; H G Ahuja; S L Allen; P Koduru; M W Schuster; P Schulman; M Bar-Eli; M J Cline
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

2.  Allele loss on short arm of chromosome 17 in breast cancers.

Authors:  J Mackay; C M Steel; P A Elder; A P Forrest; H J Evans
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

3.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

7.  Maintenance of p53 alterations throughout breast cancer progression.

Authors:  A M Davidoff; B J Kerns; J D Iglehart; J R Marks
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

8.  Pattern of p53 gene mutations in breast cancers of women of the midwestern United States.

Authors:  S S Sommer; J Cunningham; R M McGovern; S Saitoh; J J Schroeder; L E Wold; J S Kovach
Journal:  J Natl Cancer Inst       Date:  1992-02-19       Impact factor: 13.506

9.  p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas.

Authors:  T Nakamura; I Yana; T Kobayashi; E Shin; K Karakawa; S Fujita; A Miya; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1992-12

10.  Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer.

Authors:  Y Umekita; K Kobayashi; T Saheki; H Yoshida
Journal:  Jpn J Cancer Res       Date:  1994-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.